CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. There are many causes of CRS and our mission is to develop a broadly accessible treatment for multiple indications of high unmet need. Using a novel approach by calming the natural immune response to a multi organ disease, CytoAgemts' lead drug candidate, GP1681, is positioned to become a new best practice in medicine.
| Website | https://www.cytoagents.com/ |
| Employees | 10 (2 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
PHP
+18 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals |
| Keywords | Biotechnology, Pharmaceutical Products, Biopharma, Clinical Stage, Innovative Therapies, Clinical Trials, Drug Development, Immune System, Therapeutics, Pharma, Immunology, Life Threatening Diseases, New Drugs, Research, Development, Treatment, Medicine, Healthcare |
| Competitors | Roche, Novartis, Merck & Co., Inc., GSK, AstraZeneca, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, CytomX Therapeutics +43 more (view full list) |
Looking for a particular CytoAgents, Inc employee's phone or email?
CytoAgents, Inc Questions
Teresa Whalen is the CEO of CytoAgents, Inc.
2 people are employed at CytoAgents, Inc.
Top CytoAgents, Inc Employees
-
Teresa Whalen
CEO at CytoAgents, Inc
Pittsburgh, PA, US55+ -
Roy Prieb
CFO at CytoAgents, Inc
New York, NY, US35
Related Companies
